Provider
Dipeptidyl Peptidase-4 (DPP-4) Inhibitors and Combinations - Commercial
Step Therapy, Quantity Limit
Program effective Date: Jan 01, 2026
Documents & Forms Results
Displaying 3461 - 3470 of 3577 results
Provider
Corticotropin - Commercial
Prior Authorization
Program effective Date: Jan 01, 2026
Provider
Self-Administered Oncology Agents - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Jan 01, 2026
Provider
Phenylketonuria - Commercial
Prior Authorization
Program effective Date: Jan 01, 2026
Provider
Sensipar (cinacalcet) - Commercial
Prior Authorization
Program effective Date: Jan 01, 2026
Provider
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Jan 01, 2026
Provider
Pulmonary Arterial Hypertension - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Jan 01, 2026
Provider
Resmetirom - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Jan 01, 2026
Provider
Oral Inhalers - Commercial
Step Therapy, Quantity Limit
Program effective Date: Jan 01, 2026
Provider
Growth Hormone - Commercial
Prior Authorization
Program effective Date: Jan 01, 2026